Showing 34,784 results

HIV treatment

Glaxo Seeks $1.5 Billion in AIDS Drug Trial Against Abbott

Editor's pick
Bloomberg
1 March 2011
Viral load

Treatment monitoring: no clear benefit to adding viral load to CD4 or clinical symptoms in Thailand and Africa

News
1 March 2011
Finance & funding

UK aid budget refocuses 'on areas of greatest need'

Editor's pick
The Guardian
1 March 2011
New & experimental HIV treatments

Attachment inhibitor BMS-663068 potent and well-tolerated in early study

News
1 March 2011
New & experimental HIV treatments

Towards a cure for all: How we might do it

News
1 March 2011
Sexual transmission

Safer sex in the treatment era

News
1 March 2011
The search for an HIV prevention vaccine

What about a vaccine?

News
1 March 2011

Choose your runner

News
1 March 2011
Ethnic & cultural minorities

Risk of Virologic Failure 40 Percent Higher Among Blacks vs. Whites

Editor's pick
Kaiser Daily Global Health Policy Report
1 March 2011
Treatment outcomes & life expectancy

Risk of Virologic Failure 40 Percent Higher Among Blacks vs. Whites

Editor's pick
AIDSMeds
1 March 2011
New & experimental HIV treatments

Zinc finger gene therapy produces HIV-resistant CD4 T-cells

News
1 March 2011
Vaginal rings & topical PrEP

Vaginal microbicides may not be safe for rectal use: gels being reformulated

News
1 March 2011
Vaginal rings & topical PrEP

One dose of raltegravir gel three hours after sex might prevent HIV infection

News
1 March 2011

Eviplera

About HIV
March 2011
TB treatment

Antiretroviral treatment in TB patients: patients with CD4 counts below 50 need to start ART quickly

News
28 February 2011
PrEP science

Truvada PrEP remains effective against HIV with 3TC/FTC resistance in animal study

News
28 February 2011
Self-testing & home testing

Self-testing for HIV proves highly acceptable in Malawi

News
28 February 2011
Circumcision

Five years on from circumcision trial, nine in ten participants are circumcised and HIV incidence is two-thirds lower

News
28 February 2011
Pregnancy and vertical transmission

Uganda: Cash Crunch Delays Shift to WHO-Recommended PMTCT Regimen

Editor's pick
IRIN Plus News
28 February 2011
PrEP

Gilead's $12000-a-Year HIV Prevention Pill Fails to Win Physician Support

Editor's pick
28 February 2011
PrEP

Gilead's $12000-a-Year HIV Prevention Pill Fails to Win Physician Support

Editor's pick
Bloomberg
28 February 2011
Epidemiology

Zimbabwe: Who Should Have Access to Free ARVs?

Editor's pick
AllAfrica
28 February 2011
PrEP

Concept paper on medicines to prevent HIV infection released for public consultation

Editor's pick
European Medicines Agency
27 February 2011
Epidemiology

Other routes to HIV drug assistance

Editor's pick
Los Angeles Times
26 February 2011